Kapitalisasi pasar: Omeros Corp (OMER)

The market value dynamics of Omeros Corporation (OMER), which currently stands at 1.17, illustrate the position of a biopharmaceutical player with a diverse portfolio of projects in immunology, ophthalmology, and neurology. The company is currently focused on the independent development of its proprietary research and the search for strategic partners for commercialization. Holding exclusive rights to MASP-2 molecules allows the business to exercise pricing power in the therapy of inflammatory processes.

OMER Omeros Corp: Nilai pasar ing interval 04.07.2022 - 22.10.2026

OMER (omeros.com): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji Omeros Corporation (OMER):

Bagan rega Omeros|OMER - Target konsensus|Kapitalisasi pasar Omeros Corporation

Analisis fundamental perusahaan:OMER (Omeros Corp.)

Sampel barang Omeros Corp

The development progress of innovative drugs by Omeros Corporation (OMER) to combat rare inflammatory diseases is directly reflected in the public company's market capitalization. This indicator captures the total value of equity, filtering out market noise from the long-term trend. The calculation is based on the product of the current share price and the total number of outstanding securities. Growth in this metric confirms market confidence in the business's molecular research. A steady upward vector indicates the fundamental stability of the asset.

Pesaing wigati

Nilai pasar Biogen BIIB|NBIX - Biji pasar|Regencell - Kapitalisasi pasar|Nilai pasar Axsome Corp|ACADIA Pharmaceuticals (ACAD) - Nilai pasar|xenon-pharma.com - Nilai pasar|Nilai pasar Viking Therapeutics, Inc.|Kapitalisasi pasar SUPN (Supernus Pharmaceuticals, Inc.)|Kapitalisasi pasar CPRX|DNLI - Nilai pasar|Harmony Biosciences - Biji pasar|Kapitalisasi pasar biohavenpharma.com BHVN|AMLX - Nilai pasar|Nilai pasar TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Nilai pasar|Nilai pasar Anavex Life Sciences Corp (AVXL)|Nilai pasar CeriBell, Inc.|Nilai pasar Prothena Corp PRTA|Nilai pasar Alector, Inc. (ALEC)|Biji pasar Annexon Biosciences ANNX|Kapitalisasi pasar NGNE (Neurogene Corp)|AC Immune Inc (ACIU) - Nilai pasar|VYGR - Nilai pasar|Nilai pasar NMRA (neumoratx.com)|Scilex (SCLX) - Nilai pasar|Nilai pasar Tevogen Bio Holdings Inc. (TVGN)|Nilai pasar Alpha Cognition Inc|cogrx.com (CGTX) - Kapitalisasi pasar|Biji pasar IKT (Inhibikase Therapeutics)|SAVA (cassavasciences.com) - Nilai pasar|Kapitalisasi pasar ASRT (Assertio)|COYA - Biji pasar|VTGN - Nilai pasar|Nilai pasar Ovid Therapeutics Inc.|Acumen Pharmaceuticals (ABOS) - Nilai pasar|cervomed.com - Nilai pasar|Nilai pasar Alterity Therapeutics Ltd.|Clene Nanomedicine - Biji pasar|Nilai pasar PepGen Inc. (PEPG)|JUNS - Nilai pasar|Nilai pasar Relmada Therapeutics RLMD|Nilai pasar ANVS|Grace Tx - Kapitalisasi pasar|AIFF - Kapitalisasi pasar|KLTO (anewmeds.com) - Biji pasar|NRSN: Nilai pasar|RVPH (Reviva Pharmaceuticals) - Kapitalisasi pasar|MetaVia, Inc. (MTVA) - Kapitalisasi pasar|Nilai pasar NeurAxis (NRXS)|HSDT - Nilai pasar|Nilai pasar Passage Bio PASG|NEUP: Kapitalisasi pasar|NERV - Nilai pasar|Nilai pasar athira.com|Addex Therapeutics Ltd (ADXN) - Nilai pasar|Biji pasar Alzamend Neuro|CYCN (Cyclerion Therapeutics Inc.) - Kapitalisasi pasar|Nilai pasar Protagenic PTIX|Nilai pasar Pasithea Therapeutics (KTTA)|CRGT (cortigent.com) - Nilai pasar|Nilai pasar Avenue Therapeutics, Inc. ATXI|BCLI: Kapitalisasi pasar|Cara Therapeutics, Inc - Kapitalisasi pasar|Nilai pasar Chromocell|ELYM (eliemtx.com) - Biji pasar|Intra-Cellular Therapies, Inc. (ITCI) - Kapitalisasi pasar|Nilai pasar Longboard Pharmaceuticals, Inc.|MRNS: Nilai pasar|Nilai pasar NKGen (NKGN)|NRBO - Nilai pasar|Nilai pasar Sage Therapeutics, Inc. SAGE|synaptogen.com (SNPX) - Nilai pasar|TRVN - Nilai pasar|Vigil Neuroscience (VIGL) - Biji pasar|WENA: Kapitalisasi pasar|Nilai pasar Cerevel Corp (CERE)